It has been reported that BRCA2 [57], BCL2 [58], APC [59], and p16 [60] are hypermethylated in NSCLC, and P16 [60] gene promoter methylation is used as a biomarker for the diagnosis of NSCLC. Here, BRCA2 is linked to non-small cell lung carcinoma.